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BBF2H7-Mediated Sec23A Pathway Is Required for
Endoplasmic Reticulum-to-Golgi Trafficking in
Dermal Fibroblasts to Promote Collagen Synthesis
Seiko Ishikura-Kinoshita1, Hiroshi Saeki1 and Kentaro Tsuji-Naito1
Collagen fibers, structural elements responsible for mechanical strength in skin, are synthesized constitutively
in response to cytokines such as IGF-I. However, little is known about their intracellular trafficking from the
endoplasmic reticulum (ER) to the Golgi apparatus during synthesis. We demonstrate herein that the BBF2
human homolog on chromosome 7 (BBF2H7)–mediated Sec23A pathway is involved in regulation of intracellular
procollagen trafficking. The mRNA and protein expression of BBF2H7, Sec23A, and type I and III collagen (COL1
and COL3) was induced by IGF-I stimulation. In addition, the cleaved form of BBF2H7 was detected in IGF-I-
treated cultures, indicating that activation occurs concurrently with its expression. Knockdown with small
interfering RNAs targeting BBF2H7 caused a significant reduction in the expression of COL1 and COL3,
regardless of IGF-I treatment. Both mitogen-activated protein kinase and phosphatidylinositol-3 kinase
pathways via IGF-I receptor activation were required for BBF2H7 induction. Using immunofluorescence
microscopy, we showed that Golgi apparatus dysmorphology is due to coat protein complex II vehicle
hypoplasia caused by the absence of BBF2H7 and Sec23A. The BBF2H7-mediated Sec23A pathway was required
for ER-to-Golgi procollagen trafficking to promote collagen synthesis. This role of growth factors such as IGF-I,
which to our knowledge is previously unreported, suggests antiaging strategies.
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INTRODUCTION
The structure and function of healthy skin requires a well-
balanced array of extracellular matrix (ECM) components.
Although elastic fibers and polymeric glycosaminoglycans
provide skin with resiliency and hydration, collagen is
responsible for its mechanical strength (Teli, 1992). Cuta-
neous collagen fibers primarily comprise collagen types I and
III (COL1 and COL3). COL1 is responsible for tissue support,
whereas reticular fibers, such as COL3, form a scaffold for
cell migration (Liu et al., 1997). Collagen precursor mole-
cules (procollagen molecules) are synthesized in the en-
doplasmic reticulum (ER) and transported to the Golgi
apparatus for secretion into the extracellular spaces, where
they are enzymatically processed to form mature collagen.
IGF-I is a single-chain polypeptide homologous to
proinsulin (Schmid, 1995). IGF-I is involved in cell prolifera-
tion, survival, migration, and production of ECM, including
collagen fibrils, in dermal fibroblasts (Edmondson et al.,
2003). IGF-I signaling pathways in various cell systems have
been well documented (Butler et al., 1998), demonstrating
that IGF-I action results primarily from the activation of the
IGF-I receptor (IGF-IR) and its satellites, which include Src
homology 2 domain–containing transforming protein and
insulin receptor substrate. Subsequent pathways activated
include the phosphoinositide 3-kinase (PI3K) and/or mitogen-
activated protein kinase (MAPK) pathways. IGF-I is considered
to be the major growth factor responsible for the induction of
collagen synthesis in dermal fibroblasts; however, the post-
transcriptional trafficking events that follow remain unclear.
Eukaryotic cells have adapted to deal with the accumula-
tion of unfolded proteins in ER through a diverse range of
signals from the ER lumen to the cytoplasm and nucleus. This
system is termed the unfolded protein response (UPR)
(Schro¨der and Kaufman, 2005). The three major transducers
of the UPR are the inositol-requiring enzyme 1, PKR-like ER
kinase, and activating transcription factor (ATF)-6. All the
transducers sense the presence of unfolded proteins in the ER
lumen and transduce these signals to the nucleus for
transcription of UPR target genes, resulting in translational
attenuation of global protein synthesis and ER-associated
degradation (Rutkowski and Hegde, 2010). Several recent
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studies have identified BBF2 human homolog on chromo-
some 7 (BBF2H7) and old astrocyte specifically induced
substance (OASIS) as members of the cAMP response
element-binding protein (CREB)/ATF family (Nikaido et al.,
2001; Kondo et al., 2007). BBF2H7 is cleaved in the
transmembrane region by regulated intramembrane proteo-
lysis in response to ER stress and has a role in protection from
ER stress (Kondo et al., 2007). Thus, BBF2H7, a transmem-
brane bZIP transcription factor, is implicated as a novel ER
stress transducer.
Recently, a function of BBF2H7 that to our knowledge is
previously unreported has been reported in chondrogenesis:
BBF2H7 has a key role as a transmembrane bZIP transcrip-
tion factor in the expression of Sec23A (Saito et al., 2009).
Here, BBF2H7-mediated expression of Sec23A precedes
ECM trafficking from ER to Golgi in coat protein complex II
(COPII) vesicles (Fromme et al., 2008), improving the burden
on ER when cartilage matrix proteins are excessively
produced upon chondrocyte differentiation. Previous reports
demonstrate that a nonsense mutation in the Sec23A gene
underlies cranio-lenticulo-sutural dysplasia and causes
abnormal formation of the craniofacial skeleton, and in this
case loss of function of Sec23A results in defective COPII-
mediated ER export (Boyadjiev et al., 2006; Fromme et al.,
2008). Boyadjiev et al. also show that Sec23A genetic
deficiency causes a secretory disorder of COL1 in the skin,
as well as craniofacial abnormalities. These reports implicate
the involvement of the BBF2H7–Sec23A pathway in the
biosynthesis of the collagenous network of the dermis, but
the mechanisms by which this occurs remain unclear. In this
study, we demonstrate that the BBF2H7-mediated Sec23A
pathway is involved in IGF-I-induced constitutive dermal
collagen synthesis.
RESULTS
IGF-I promotes the expression of BBF2H7 and Sec23A in
NHDFs
Recent reports indicate that the BBF2H7–Sec23A pathway
contributes to constitutive dermal collagen biosynthesis.
However, little is known about its mechanism in the dermis.
We examined IGF-I-derived collagen synthesis, which
principally serves to produce collagen fibrils in the dermis,
to clarify the roles of BBF2H7 and Sec23A in normal human
dermal fibroblasts (NHDFs). To investigate the synthesis of
COL1 and COL3 in NHDFs through IGF-I stimulation, we
first validated their temporal mRNA expression profiles. As
shown in Figure 1a, the mRNA expression of Col1 and Col3
in NHDFs increased in a time-dependent manner within
24 hours by IGF-I treatment (50 mgml1). To determine the
expression and maturation of these collagen proteins in IGF-
I-stimulated NHDFs, we assessed protein levels of procolla-
gen and collagen using immunoblot analyses. Protein levels
of procollagen and collagen also gradually increased
(Figure 1b) until 48 hours after stimulation. Furthermore,
we assessed the expression levels of proline 4-hydroxylase
(P4H), which is the rate-limiting enzyme in collagen
synthesis and stabilizes the collagen triple helix (Pinnel
et al., 1987), in NHDFs following IGF-I treatment. As shown
in Figure 1c and d, IGF-I stimulation induces mRNA and
protein expression of P4H and collagen. These results
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Figure 1. IGF-I upregulates the expression of COL1, COL3, and proline 4-hydroxylase (P4H) in normal human dermal fibroblast (NHDF) cultures. NHDF
cultures were starved for 24 hours, followed by treatment with IGF-I (50 ngml1) for the indicated time. The expression levels of (a) Col1, Col3, and (c) P4h were
quantified using real-time PCR. (b, d) Whole-cell lysates were examined by immunoblotting with antibodies for COL1, COL3, P4H, and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH). Values represent mean±SD of triplicate determinations (*Po0.05; **Po0.01 (Tukey–Kramer test)).
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indicate that synthesis of COL1 and COL3 is activated by
IGF-I stimulation, and that collagen progresses from expres-
sion to maturation within 24 hours.
Next, we examined whether IGF-I induces BBF2H7 during
elevated collagen production in NHDFs. mRNA expression
of Bbf2h7 markedly increased at 4–8 hours after initiation of
IGF-I treatment and was attenuated at 24 hours (Figure 2a).
Analysis of protein levels in IGF-I-treated cells showed that
the levels of cleaved and full-length BBF2H7 were elevated
between 8–24 hours and at 24 hours, respectively, and
characteristically peaked at 24 hours (Figure 2b). Thapsigar-
gin, a well-known ER stressor that induces BBF2H7, was used
as a positive control.
Further study of cranio-lenticulo-sutural dysplasia suggests
that abnormal ER-to-Golgi trafficking, caused by a Sec23A
mutation, leads to a deficiency of collagen secretion in the
skin, as well as skeletal defects (Boyadjiev et al., 2006). Thus,
we investigated whether Sec23A is induced by IGF-I
stimulation. We demonstrated that the mRNA expression
of Sec23a increased 4–8 hours after IGF-I stimulation in
a manner similar to that of Bbf2h7 (Figure 2c). Analysis of
protein levels showed that the expression of Sec23A induced
by IGF-I tended to increase at 4–12 hours, and was greatly
enhanced at 24 hours (Figure 2d). These results show that
IGF-I induces the expression and activation, through cleavage
at the membrane region by regulated intramembrane
proteolysis, of BBF2H7 and Sec23A.
BBF2H7 is involved in the expression of COL1 and Sec23A
induced by IGF-I stimulation
In chondrocytes, BBF2H7 functions as a transcriptional factor
for Sec23A (Saito et al., 2009). To assess the necessity of
BBF2H7 for Sec23A in NHDFs after treatment with IGF-I, we
created a Bbf2h7 knockdown system. Small interfering RNAs
(siRNAs) against Lamin A/C, a nuclear envelope protein, were
used as controls according to a previous study (Townley
et al., 2008). Townley et al. showed that Lamin A/C
knockdown does not influence collagen secretion or expres-
sion of COPII vesicle proteins. Knockdown of Bbf2h7 and
Lamin A/C reduced their expressions to approximately 10%
and 30%, respectively (Supplementary Figure S1 online).
Knockdown of Bbf2h7 in NHDFs caused a decrease in the
expression of Sec23a relative to that in Lamin A/C-knock-
down cultures, both in the absence and presence of IGF-I
(Figure 3a). This suggests that BBF2H7 is essential for the
induction of Sec23a mRNA in dermal fibroblasts and
chondrocytes. Interestingly, Bbf2h7-knockdown fibroblast
cells showed a decrease in mRNA and protein expression
levels of COL1 (Figure 3b and c) and COL3 (data not shown)
regardless of IGF-I treatment, although P4h levels showed
almost no difference between the two cells (Supplementary
Figure S2 online). At first, we expected that the knockdown of
Bbf2h7 would have no effect on COL1 and COL3 expression,
as levels of type II collagen and related proteins in Bbf2h7/
chondrocyte cells have been shown to be almost equal to
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Figure 2. IGF-I upregulates the expression of BBF2 human homolog on chromosome 7 (BBF2H7) and Sec23A. Normal human dermal fibroblast (NHDF)
cultures were starved for 24hours, followed by treatment with IGF-I (50 ngml1) or thapsigargin (Tg; 1mM) for the indicated time. The expression levels of (a) Bbf2h7
and (c) Sec23a were quantified using real-time PCR. (b, d) Whole-cell lysates were examined by immunoblotting with antibodies for BBF2H7, Sec23A, and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Values represent mean±SD of triplicate determinations (*Po0.05; **Po0.01 (Tukey–Kramer test)).
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those in wild-type cells (Saito et al., 2009). This intriguing
discrepancy could be accounted for by the possibility that
constitutive activation of COL1 and COL3 promoters in
dermal fibroblasts is regulated through the binding of p60
BBF2H7 to the UPR element (UPRE)–like sequence. OASIS, a
bZIP transcriptional factor structurally very similar to
BBF2H7, binds to the promoter region of endogenous
COL1 to induce its transcription in osteoblasts (Murakami
et al., 2009). These results suggest that IGF-I could regulate
dermal collagen synthesis by potentiating the expression and
activation of Sec23A and BBF2H7.
IGF-I-inducible BBF2H7 is upregulated via the PI3K and MAPK
pathways on IGF-IR activation to enhance collagen synthesis
Although the indispensability of IGF-IR activation for trigger-
ing IGF-I downstream signaling is well documented in
various cell models (Butler et al., 1998), it remains unclear
how BBF2H7 is activated following IGF-I stimulation in
dermal fibroblasts. AG1024—a ligand specific for IGF-IR—
causes a highly efficient decrease in IGF-I-induced collagen
formation (Figure 4a), according to published criteria
(Goldstein et al., 1989). We examined the participation
of IGF-IR activation in IGF-I-derived BBF2H7 expression.
As shown in Figure 4b, addition of 10 mM Tyrphostin
AG1024 resulted in inhibition of the expression of Bbf2h7
induced by IGF-I to approximately that of untreated
cultures, indicating that IGF-I induces the expression of
BBF2H7 via activation of IGF-IR. We further examined
whether signaling pathways downstream of IGF-IR, such as
the MAPK and PI3K pathways, are involved in BBF2H7
expression. Validation was conducted using the following
two inhibitors: wortmannin, a specific covalent inhibitor
of PI3K, and sorafenib, an inhibitor of Raf kinase in the
MAPK pathway. As shown in Figure 4b, both inhibitors
suppressed the induction of Bbf2h7 mRNA after IGF-I
treatment. These results suggest that IGF-I induces BBF2H7
expression through the PI3K and MAPK pathways under-
lying IGF-IR activation.
The BBF2H7–Sec23A pathway is concerned with collagen
trafficking in NHDFs
Previously, Farhan et al. (2010) proposed a new cargo-based
motif using an siRNA-based knockdown approach, and
defined indicators of a trafficking defect. Subcellular trafficking
errors are indicated by morphological changes of the Golgi
apparatus, depicted as a ‘‘fragmented’’ apparatus, and
mislocalization of the membrane lectin ER–Golgi intermediate
compartment-53 (ERGIC-53; Lucocq et al., 1991). To inves-
tigate the involvement of the BBF2H7–Sec23A pathway in
endogenous collagen trafficking, Golgi morphologies in
knockdown cultures in Lamin A/C, Sec23a, and Bbf2h7 were
evaluated using double immunofluorescence microscopic
analyses, with visualization of endogenous ERGIC-53 and
GM130 (a Golgi marker). In the prespecified analysis, knock-
down of Sec23a reduced its expression to o10% (Supple-
mentary Figure S1 online) and also reduced the levels of COL1
mature protein irrespective of IGF-I stimulation (data not
shown). ERGIC-53 mislocalization was not observed in either
Bbf2h7 or Sec23a knockdown cells. On the other hand,
Bbf2h7 or Sec23a knockdown increased the prevalence of
irregularly curved Golgi cisternae accompanied by aggrega-
tion, characteristic of Golgi dysmorphology (Figure 5e and f),
whereas Lamin A/C knockdown resulted in Golgi apparatus
with normal flat cisternae (Figure 5d). Quantitative analysis
revealed that the number of cells showing Golgi dysmorphol-
ogy significantly increased with Bbf2h7 or Sec23a knockdown
compared with Lamin A/C knockdown (Figure 5j). Bbf2h7 and
Sec23a knockdown cells exhibiting Golgi dysmorphology
were approximately 65% and 75%, respectively, relative to
about 20% with Lamin A/C knockdown. These results indicate
that a BBF2H7-mediated Sec23A signaling deficiency causes
disruption of ER-to-Golgi trafficking.
DISCUSSION
Cutaneous collagen fibers have a central role in dermal
mechanical strength as a component of ECM. Constitutive
assemblies are principally initiated by growth hormone
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and growth factors, such as IGF-I, but little is known about
their intracellular trafficking during their synthesis. In this
study, we demonstrate that IGF-I-inducible trafficking of
constitutive type I/III procollagen is regulated by the
BBF2H7-mediated Sec23A pathway. We initially demon-
strated that the expression of BBF2H7 and Sec23A is induced
by IGF-I stimulation (Figure 2), similar to COL1, COL3, and
P4H. In particular, the cleavage fragment of BBF2H7 in IGF-
I-treated cultures was detected by immunoblot analysis,
indicating that IGF-I promotes its activation following its
expression.
Subsequently, siRNA studies revealed that BBF2H7
deficiency causes a significant reduction in the expression
of Sec23A induced by IGF-I stimulation (Figure 3a–c), which
is in accordance with previous studies in Bbf2h7/ mice
(Saito et al., 2009). Conversely, the expression of COL1 and
COL3 was also affected by knockdown of Bbf2h7, although a
previous report demonstrated that BBF2H7 deficiency in
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chondrocytes did not affect the expression of type II collagen
(Saito et al., 2009). We suggest that this discrepancy can be
attributed to the different role of BBF2H7 in these diverse
heterocellular models. We propose that linkage of BBF2H7
with Col1 and Col3 promoter regions—namely UPRE-like
sequences—in dermal fibroblasts but not in chondrocytes
may be responsible for the high expressions of Col1 and Col3.
A recent report demonstrates that OASIS, which acts as a
bone-specific transcriptional factor, binds to the Col1-UPRE-
like promoter region, resulting in the promotion of osteo-
blastogenesis (Murakami et al., 2009). In fact, the expression
of P4h, a gene essential for collagen folding, was not affected
by BBF2H7 deficiency, resembling findings in OASIS/
models (Supplementary Figure S2 online). Our results raise
the possibility that COL1 and COL3 are direct targets of
BBF2H7 in a dermal fibroblast–specific manner.
Under mild ER stress in dermal fibroblasts, IGF-I-inducible
BBF2H7 could be activated through regulated intramem-
brane proteolysis in ER (Scheme 1), as it is known that it is
transiently induced in chondrocytes and osteoblasts during
normal differentiation (Murakami et al., 2009; Saito et al.,
2009). Indeed, in NHDFs under IGF-I treatment, the
expression levels of CHOP, an ER stress-related gene, and
subsequent activation levels of caspase-3 were equal to those
in untreated cultures; however, the ER stressor thapsigargin
significantly promoted the expression of CHOP and caspase-
3 (Supplementary Figure S3 online).
We also examined the involvement of the IGF-I signaling
pathway in dermal collagen synthesis. IGF-I promoted the
expression and regulated intramembrane proteolysis of
BBF2H7 in an IGF-IR-dependent manner (Figure 4b), leading
to the induction of collagen biosynthesis (Figure 4a). In
malignant gliomas, BBF2H7 has been previously reported to
induce the ATF5-mediated survival pathway via the MAPK
and PI3K pathways downstream of the fibroblast growth
factor receptor, classified as receptor tyrosine kinase (Sheng
et al., 2010). Similarly, we demonstrated that both the MAPK
and PI3K pathways downstream of IGF-IR were required for
BBF2H7 induction (Figure 4c), raising the possibility that the
BBF2H7-mediated pathway may be upregulated by cross-talk
between these two pathways. On the other hand, previous
studies showed that the ERK1/2 pathway downregulated
expression of Col1 and Col3 in dermal fibroblasts after
C2-ceramide or interleukin-18 stimulation (Reunanen et al.,
2000; Kim et al., 2010). We further investigated the effects of
other inhibitors, such as LY294002 (a PI3K inhibitor) and
PD98059 and U0126 (MEK inhibitors), on these pathways.
All three inhibitors suppressed BBF2H7 induction by IGF-I
stimulation, similar to wortmannin and sorafenib (Supple-
mentary Figure S4a online). In addition, we observed that
U0126 inhibited BBF2H7 induction in a dose-dependent
manner (Supplementary Figure S4b online), suggesting that
the ERK1/2 pathway is required for BBF2H7 induction.
Reunanen et al (2000) proposed that the effects of ERK1/2
activation on expression of COL1 were cell specific;
however, the negative effect of ERK 1/2 activation in dermal
fibroblasts is not applicable to our model. We speculated that
this interesting discrepancy might be relevant not only in a
cell-specific manner but also in individual signaling systems
among several stimuli such as IGF-I that work for collagen
synthesis, although further studies have to be conducted
to verify. In addition, we investigated the involvement of
activation of serine/threonine-protein kinase receptors, such
as transforming growth factor-beta (TGF-b) receptor, in
IGF-I
IGF-IR AG1024
Collagen fibril
PI3K pathwayMAPK pathway
Sorafenib
Raf PI3K
BBF2H7 mRNA
Full-length
BBF2H7
p60
BBF2H7
ER
ER to Golgi trafficking
Golgi
Procollagen
Sec23A
Col1, Col3, Sec23a
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Scheme 1. Proposed mechanisms responsible for collagen synthesis by the BBF2 human homolog on chromosome 7 (BBF2H7)–Sec23A pathway in dermal
fibroblasts. ER, endoplasmic reticulum; IGF-IR, IGF-I receptor.
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cutaneous collagen synthesis, and found a new pathway
activating BBF2H7 in a receptor tyrosine kinase–independent
manner (data not shown), unequivocally indicating that the
BBF2H7-mediated pathway in the dermis is constitutively
regulated via several routes.
As shown in Figure 5e, we visualized BBF2H7 involve-
ment in Sec23A-mediated trafficking of procollagen in
NHDFs. Golgi apparatus dysmorphology was caused by the
knockdown of Bbf2h7 (Figure 5f) and Sec23a (Figure 5e),
presumably due to COPII vehicle hypoplasia in the absence
of Sec23A (Townley et al., 2008). During mitosis, it is known
that ER exit sites disassemble, ER-to-Golgi vesicular traffick-
ing is inhibited, and the Golgi apparatus is fragmented (Kano
et al., 2004). Our results demonstrate that the BBF2H7–Se-
c23A pathway is required for ER-to-Golgi trafficking in
NHDFs, to promote collagen synthesis.
Our findings provide new approaches to improve the signs
and symptoms of aged skin, as a decrease in dermal collagen
production, which may be partly due to intercellular
retention of procollagen molecules and a decrease in IGF
responsiveness, is considered to be its principal cause
(Miyaishi et al., 1995; Edmondson et al., 2003). Although
the mechanisms underlying intercellular procollagen retention
are not completely understood, it is likely that ER-to-Golgi
vesicular trafficking errors are responsible for deposition of
procollagens in aged skin. Recent evidence has shown
that Sec31L2, which functions in collagen secretion as
another component of COPII vesicles, is a characteristic
target of DNA methylation in aged human skin to undergo
epigenetic gene silencing. This suggests that hypermethyla-
tion-associated Sec31L2 silencing could have an important
role in the age-associated skin phenotype (Gro¨nniger et al.,
2010). In addition, Miyaishi et al. demonstrated that the
retention of procollagen molecules is much greater in the ER
lumen of cells from elderly individuals than in those from
young individuals. This results from attenuation of the 47-
kDa heat-shock protein that has a key role as a collagen-
specific molecular chaperone in fibrosis of various organs
(Miyaishi et al., 1995). Thus, age-related attenuation in the
BBF2H7-mediated Sec23A pathway may contribute to the
retention of procollagens during aging. Several recent reports
support our hypothesis by decline in the UPR system that the
expression of ER stress transducers, including the CREB/ATF
family, have declined during aging (Naidoo, 2009; Salminen
and Kaarniranta, 2010). Both intrinsic and extrinsic aging are
characterized by damaged and disorganized collagen fibrils,
suggesting that promotion of collagen synthesis could help
protect dermal homeostasis from aging (Cutroneo, 2003).
Recently, topical applications of growth factors and cytokines
for skin rejuvenation and the reversal of photoaging have
attracted attention as new cosmeceutical treatments for aging
(Mehta and Fitzpatrick, 2007). In addition, several studies have
reported that natural products and compounds promote collagen
synthesis through the activation of growth factor pathways,
indicating that a better understanding of the roles of growth
factors is needed in antiaging studies (Lee et al., 2006;
Takasao et al., 2012). Accordingly, understanding the
detailed signaling pathways involved, such as collagen
trafficking, may offer new strategies, for instance potentiat-
ing dermal IGF responsiveness, for treating and preventing
the visible signs of aging.
In this study, we elucidated the BBF2H7-regulated
transcriptional and posttranscriptional mechanisms of dermal
collagen synthesis after IGF-I stimulation. Our key findings
are as follows: (a) BBF2H7 promotes the expression of type I/
III procollagen and Sec23A, and (b) the BBF2H7-mediated
Sec23A pathway is homeostatically involved in the ER-to-
Golgi trafficking of procollagen. Further studies on the role of
BBF2H7 will be necessary in the future to better understand
the dermal collagen network.
MATERIALS AND METHODS
Reagents
IGF-I was purchased from R&D systems (Minneapolis, MN). TGF-b
was obtained from PeproTech (Rocky Hill, NJ). Thapsigargin and
Tyrphostin AG 1024 were purchased from Sigma-Aldrich (St Louis,
MO). Wortmannin was obtained from Cayman Chemical (Ann
Arbor, MI). Sorafenib was purchased from Toronto Research
Chemicals (Ontario, Canada).
Antibodies
Anti-COL1 was purchased from Millipore (Billerica, MA), anti-COL3
and anti-CHOP from Santa Cruz Biotechnology (Santa Cruz, CA),
anti-Sec23A and anti-ERGIC-53 from Sigma-Aldrich, anti-BBF2H7
from Protein tech Group (Chicago, IL), anti-P4HA1 from Abnova
(Walnut, CA), anti-caspase-3 from Cell Signaling Technology
(Danvers, MA), anti-glyceraldehyde-3-phosphate dehydrogenase
from Ambion (Austin, TX), anti-GM130 from BD Biosciences
(San Jose, CA), horseradish peroxidase–conjugated anti-rabbit IgG
from BD Biosciences and anti-mouse IgG from Invitrogen
(Carlsbad, CA). Alexa Fluor 594 donkey anti-mouse IgG antibody
and Alexa Fluor 488 goat anti-rabbit IgG antibody were also
obtained from Invitrogen.
Cell cultures
NHDFs (newborn/male, Kurabo Industried, Osaka, Japan) were
cultured in Kurabo’s modified Medium 106S, supplemented with
2% fetal bovine serum and human skin fibroblast growth supplement
(Kurabo Industried), at 37 1C in a humidified atmosphere of 5% CO2.
NHDFs were assayed for proliferation and used for all other
experiments.
Immunoblotting
NHDFs were lysed with a lysis buffer (150mM NaCl, 10mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid, pH 7.8, 1% NP-40,
2mM EDTA, 1.5mM MgCl2, 0.5mM dithiothreitol, and protease
inhibitors). Each extract was subjected to SDS-PAGE electrophoresis,
and proteins were transferred to polyvinylidene fluoride membranes
using a semidry blotter (Biocraft, Tokyo, Japan) and incubated in a
blocking solution (5% dried skim-milk in Tris-buffered saline (TBS)
containing 0.1% Tween-20 (TBS-T)) for 1 hour to reduce nonspecific
binding. Membranes were then exposed to primary antibodies
overnight at 4 1C. The blots were washed, exposed to horseradish
peroxidase–conjugated secondary antibodies for 1 hour, and de-
tected using the ECL Plus Western Blotting Detection System (GE
Healthcare Biosciences, Piscataway, NJ).
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RNA isolation and real-time PCR
Total RNA was isolated using the RNeasy Mini Kit (Qiagen,
Mississauga, ON), following the manufacturers’ instructions. RNA
was stored in RNase-free water at –80 1C until reverse transcription.
First-strand cDNA synthesis was performed using the PrimeScript II
High Fidelity RT-PCR Kit (Takara, Shiga, Japan) according to the
manufacturers’ instructions. For expression studies, the target
transcripts were amplified and expression levels were measured
using the Applied Biosystems 7500 Real Time PCR system
(Applied Biosystems, Foster City, CA), using the following TaqMan
Gene Expression Assays: Col1 (assay ID: Hs00164004_m1); Col3
(assay ID:Hs00943809_m1); P4h (assay ID: Hs00914594_m1);
Bbf2h7 (assay ID: Hs00811200_m1); Sec23a (assay ID:
Hs00197232_m1); 18S (assay ID: Hs99999901_s1). 18S was used
as the housekeeping gene for quantity normalization, and all data
are presented as the fold change against each control (i.e., each
untreated group).
RNA silencing
For the siRNA studies, siRNAs targeting Bbf2h7 and Sec23a were
purchased from Thermo Fisher Scientific (Waltham, MA) and Santa
Cruz Biotechnology, respectively. Lamin A/C-siRNA (Qiagen) was
used as a positive silencing control. NHDFs (2.0 105 cells) in six-
well plates were transfected with Bbf2h7, Sec23a, or Lamin A/C
siRNA (20 nM) plus HiPerFect Transfection Reagent (Qiagen)
according to the manufacturers’ instructions for mRNA silencing in
the cells. The efficiency of siRNA-mediated repression of target
mRNA levels was assessed by real-time PCR.
Immunochemistry and quantification
Cells were fixed in 4% formaldehyde in phosphate-buffered saline
(PBS) for 10minutes, washed three times with PBS, and permeabi-
lized with 1% Triton X-100-containing PBS for 20minutes. After
washing three times with PBS, cells were blocked with 5% skim milk
in TBS-T (50mM Tris-HCl, pH 8.0, 150mM NaCl, and 0.05% Tween
20). After washing with TBS-T, cultures were incubated with primary
antibodies overnight at 4 1C. They were washed three times with
TBS-T, and exposed to fluorescent dye–conjugated secondary
antibodies for 1 hour. Upon their encapsulation, each sample was
examined under a Leica confocal fluorescence microscope (Leica
Microsystems Japan, Tokyo, Japan). The number of cells displaying
Golgi dysmorphology was counted and converted into cell number
per well. NHDFs were cultured at a concentration of 2 105 cells
per well in six-well plates.
Statistical analyses
The data are expressed as mean±SD from at least three independent
experiments. Statistical analyses were performed using the Tukey–
Kramer test.
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